Stockreport

Praxis Precision Medicines Announces Pricing of Upsized Initial Public Offering

Praxis Precision Medicines, Inc.  (PRAX) 
PDF CAMBRIDGE, Mass., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic ins [Read more]